| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EX03 | B | Pazopanib HCl - 200mg | 12290 | 38424/1 | VOTRIENT | 200mg | 30 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharmaceuticals Manufacturing LLC | Slovenia | 35,112,293 L.L | 19.35 | D | Novartis Pharma AG | Switzerland | 10/11/20 |
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EX03 | B | Pazopanib HCl - 200mg | 8791 | 120616/1 | VOTRIENT | 200mg | 30 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Siegfried Barbera SL | Spain | 31,567,504 L.L | 19.35 | D | Novartis Pharma AG | Switzerland | 10/11/20 |

